Selective Estrogen Receptor Modulators A New Brand of Multitarget Drugs /

The increasing awareness on the varied consequences of hypogonadism in distinct organs and systems has supported the notion of estrogens as systemic agents. This observation is congruent with the variety of tissues affected by - trogens when used in hormone therapy formulations on hypogonadic women....

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Cano, Antonio (Editor ), Calaf i Alsina, Joacquim (Editor ), Duenas-Diez, Jose Luis (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2006.
Edición:1st ed. 2006.
Temas:
Gynecology .
Rheumatology.
Endocrinology.
Gynecology.
Acceso en línea:Texto Completo
Tabla de Contenidos:
  • Basic Area
  • Molecular Mechanisms of Estrogen Action in Target Tissues
  • Clinical Pharmacology of Selective Estrogen Receptor Modulators (SERMs)
  • Action of Selective Estrogen Receptor Modulators (SERMs) Through the Classical Mechanism of Estrogen Action
  • Cellular and Molecular Basis for Acute Nongenomically Mediated Actions of SERMs
  • The Hypothalamus-Pituitary-Ovarian Axis as a Model System for the Study of SERM Effects: An Overview of Experimental and Clinical Studies
  • Pure Antiestrogens
  • Clinical Area
  • Physiological Regulation of Bone Metabolism and Estrogen Agonism
  • The Role of SERMs in the Treatment of Osteoporosis
  • Cardiovascular Disease and SERMs
  • SERMs and the Breast
  • Endometrial Effects of SERMs
  • Benign Gynecological Diseases and SERMs
  • Other Clinical Effects of SERMs
  • The Role of SERMs in the Management of Postmenopausal Women.

Ejemplares similares